References
Cosentino C, Contento M, Paganini M, Mannucci E, Cresci B (2019) Therapeutic options in a patient with MELAS and diabetes mellitus: follow-up after 6 months of treatment. Acta Diabetol. https://doi.org/10.1007/s00592-019-01302-z
Finsterer J, Frank M (2015) Glucocorticoids for mitochondrial disorders. Singapore Med J 56:122–123
Finsterer J, Frank M (2017) Gastrointestinal manifestations of mitochondrial disorders: a systematic review. Therap Adv Gastroenterol 10:142–154
Yu L, Xie S, Xiao J, Wang Z, Zhang X (2013) Quantitative measurement of cerebral oxygen extraction fraction using MRI in patients with MELAS. PLoS ONE 8(11):e79859. https://doi.org/10.1371/journal.pone.0079859
Hovsepian DA, Galati A, Chong RA, Mazumder R, DeGiorgio CM, Mishra S, Yim C (2019) MELAS: monitoring treatment with magnetic resonance spectroscopy. Acta Neurol Scand 139:82–85
Author information
Authors and Affiliations
Contributions
JF was involved in design, literature search, discussion, first draft, critical comments.
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from the patient included in the case report.
Additional information
Managed by Massimo Porta.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Finsterer, J. MELAS requires broad clinical and genetic work-up. Acta Diabetol 56, 1087–1088 (2019). https://doi.org/10.1007/s00592-019-01360-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-019-01360-3